Buscar
Mostrando ítems 21-30 de 217
Contribuição da densidade do PSA para predizer o câncer da próstata em pacientes com valores de PSA entre 2,6 e 10,0 ng/ml
(Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, 2011-08-01)
OBJECTIVE: To study the profile of patients with PSA level between 2.6 and 10.0 ng/ml and submitted to prostate biopsy, determining possible patterns that might lead to a reduction of unnecessary biopsies. MATERIALS AND ...
Feasibility of Detecting Prostate Cancer by Ultraperformance Liquid Chromatography-Mass Spectrometry Serum Metabolomics
(American Chemical Society, 2014-06)
Prostate cancer (PCa) is the second leading cause of cancer-related mortality in men. The prevalent diagnosis method is based on the serum prostate-specific antigen (PSA) screening test, which suffers from low specificity, ...
Androgen Deprivation Therapy And Morbid Obesity: Do They Share Cardiovascular Risk Through Metabolic Syndrome?
(Ene Ediciones SlMadridEspanha, 2011)
Evolution of mortality by prostate cancer in Colombia: An ecological study
Introduction and objectives: There is a worldwide increase in the incidence of prostate cancer, which is associated with longer life expectancy and the use of prostate-screening. Although mortality rates for prostate cancer ...